IN THIS ARTICLE
What should I discuss with my healthcare provider before receiving vincristine (Oncovin, Vincasar PFS)?
You should not use this medication if you are allergic to it, or if you have Charcot-Marie-Tooth syndrome.
If you have any of these other conditions, you may need a dose adjustment or special tests to safely use this medication:
FDA pregnancy category D. Vincristine can cause harm to an unborn baby or cause birth defects. Before you receive vincristine, tell your doctor if you are pregnant. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment.
It is not known whether vincristine passes into breast milk or if it could harm a nursing baby. Before you receive this medication, tell your doctor if you are breast-feeding a baby.
How is vincristine given (Oncovin, Vincasar PFS)?
Vincristine is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be given slowly through an IV infusion.
Vincristine is usually given once per week. Follow your doctor's instructions.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.
To be sure this medication is helping your condition and not causing harmful effects, your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests. Do not miss any scheduled visits to your doctor.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?